查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618262

醫療用線粒子加速器:市場洞察·競爭環境·市場預測 (～2030年)

Medical Linear Particle Accelerator - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

醫療直線粒子加速器市場規模預計將從 2023 年的 25.6 億美元增長到 2030 年的 33.9 億美元，預測期內複合年增長率為 4.79%。 由於各種癌症盛行率的增加、產品開發活動的增加以及各種醫用線性粒子加速器的可用性等因素，醫用線性粒子加速器市場正在顯著增長。

醫用直線粒子加速器：市場動態

根據世界衛生組織（WHO）2024年提供的數據，國際癌症研究機構（IARC）表示，2022年全球新增癌症病例達2,000萬例。據同一消息來源稱，在登記的新癌症病例中，全球新增肺癌病例達250萬例，成為最常見的癌症。其次是乳癌（230萬例）、大腸癌（190萬例）和胃癌（97萬例）。

隨著癌症發生率的上升，醫療保健系統正在尋求有效且精確的放射治療方案，以滿足不同地區不斷增長的患者需求，從而推動市場成長。

按治療類型劃分，影像導引放射治療領域將在 2023 年佔據顯著的收入佔有率。這是由於其在治療複雜癌症方面的高精度和適應性。

該技術整合了高解析度成像和放射傳輸，使臨床醫生能夠即時可視化腫瘤和周圍的解剖結構。這種能力對於準確定位腫瘤至關重要，特別是那些位於移動區域或靠近敏感結構（例如肺部或腹部）的腫瘤。

本報告提供全球醫療用線粒子加速器的市場調查，彙整市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 醫療用線粒子加速器市場報告:簡介

  • 調查範圍
  • 市場分類
  • 市場估計

第2章 醫療用線粒子加速器市場:摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 醫療用線粒子加速器市場:主要要素分析

  • 推動市場要素
    • 癌症病例數不斷增加
    • 增加產品開發活動
    • 各種醫用線性粒子加速器的可用性
  • 市場限制與課題
    • 缺乏熟練的專業人員來操作和處理設備
    • 與醫用直線粒子加速器相關的潛在風險
  • 市場機會
    • 整合人工智慧和機器學習以提高準確性
    • 進入新興市場

第6章 醫療用線粒子加速器市場:波特的五力分析

第7章 醫療用線粒子加速器市場評估

  • 各產品類型
    • 專用線性加速器
    • 非專用線性加速器
  • 各治療類型
    • 強度調控放射治療
    • 容量調變電弧療法
    • 影像導航放射治療
    • 定位放射線手術/定位體部放射治療
  • 各終端用戶
    • 醫院·診療所
    • 放射線科診所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 醫療用線粒子加速器市場:企業·產品簡介

  • Elekta
  • Accuray Incorporated
  • SHINVA MEDICAL INSTRUMENT CO., LTD.
  • VIEWRAY TECHNOLOGIES, INC.
  • Altair Technologies, Inc.
  • AccSys Technology, Inc.
  • S.I.T. Sordina IORT Technologies S.p.A.
  • Siemens Healthcare GmbH
  • Brainlab AG
  • Panacea Medical Technologies Pvt. Ltd.
  • MITSUBISHI HEAVY INDUSTRIES, LTD.

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明·聯絡方式

Product Code: DIMDCL0187

Medical linear particle accelerator market by Product Type (Dedicated Linear Accelerator and Non-Dedicated Linear Accelerator), Treatment Type (Intensity Modulated Radiation Therapy, Volumetric Modulated Arc Therapy, Image Guided Radiation Therapy, and Stereotactic Radiosurgery/Stereotactic Body Radiotherapy), End-User (Hospital, Radiology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of cancers and the rising product developmental activities across the globe

The medical linear particle accelerator market was valued at USD 2.56 billion in 2023, growing at a CAGR of 4.79% during the forecast period from 2024 to 2030 to reach USD 3.39 billion by 2030. The medical linear particle accelerator market is experiencing significant growth due to the increasing cases of different types of cancers among the population, rising product developmental activities, and the availability of a wide variety of medical linear particle accelerators acting as major factors contributing to the overall growth of the medical linear particle accelerator market during the forecast period from 2024 to 2030.

Medical Linear Particle Accelerator Market Dynamics:

According to data provided by the World Health Organization in 2024, the International Agency for Research on Cancer (IARC) stated that 20 million new instances of cancer were registered in 2022 globally. As per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. Next in order of incidence was breast cancer with 2.3 million cases, colon cancer with 1.9 million cases, and stomach cancer with 0.97 million cases globally.

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by 2030. It stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

As cancer rates climb, healthcare systems seek effective, precise radiation treatment options, fueling medical linear particle accelerators market growth to meet expanding patient needs across diverse regions.

Various product developmental activities by key market players will further boost the market for the same. For instance, in May 2024, Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high-definition AI-enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments. This highly versatile CT-Linac will enable clinicians to choose the most suitable radiation therapy technique for each patient.

Hence, the interplay of all the above-mentioned factors are expected to drive the medical linear particle accelerator market during the given forecast period from 2024 to 2030.

However, the dearth of skilled specialists for equipment operation and handling, potential risks associated with medical linear particle accelerators, and others may restrict the market growth for the medical linear particle accelerator market.

Medical Linear Particle Accelerator Market Segment Analysis:

Medical linear particle accelerator market by Product Type (Dedicated Linear Accelerator and Non-Dedicated Linear Accelerator), Treatment Type (Intensity Modulated Radiation Therapy, Volumetric Modulated Arc Therapy, Image Guided Radiation Therapy, and Stereotactic Radiosurgery/Stereotactic Body Radiotherapy), End-User (Hospital, Radiology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the treatment type segment of the medical linear particle accelerator market, the image-guided radiation therapy category is expected to have a significant revenue share in the year 2023. This is due to its high precision and adaptability in treating complex cancers.

This technology integrates high-resolution imaging with radiation delivery, allowing clinicians to visualize the tumor and surrounding anatomy in real-time. This capability is crucial for accurately targeting tumors, especially in areas where movement occurs, such as the lungs or abdomen, as well as for tumors located near sensitive structures.

Real-time imaging allows clinicians to adjust the radiation beam during treatment, adapting to changes in tumor position or size between sessions, a feature known as adaptive radiotherapy. By sparing healthy tissues and delivering radiation precisely to the tumor site, image guided radiation therapy reduces side effects and improves treatment efficacy.

Additionally, in March 2023, GenesisCare, one of the leading integrated cancer care providers, launched ViewRay's advanced MRIdian MRI-guided radiation therapy system. Providing access to the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy in a community cancer care setting may help reduce the burden of cancer treatment for patients who choose GenesisCare.

Therefore, the widespread uses and various advantages of image-guided radiation therapy category enhance performance and usability, solidifying a significant impact on the growth of the overall medical linear particle accelerator market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall medical linear particle accelerator market:

Among all the regions, North America is estimated to hold a significant revenue share in the medical linear particle accelerator market. This can be attributed to several factors such as the rising cancer cases, and the continuous advancements in this field, which offers improved treatment features and efficiency, which are the major key factors that contribute to the growth of the medical linear particle accelerator market in the North America region during the forecast period from 2024 to 2030.

National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it is estimated that prostate, lung, and colorectal cancers are expected to represent approximately 48% of all cancer diagnoses in men. For women, the most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.

According to Global Cancer Observatory's data (2024), in 2022, the US represented 89.1% of all cancer cases and Canada represented 10.9% of all cancer cases in the region.

With the US expected to account for a substantial proportion of these cancer cases, healthcare providers are compelled to enhance their cancer treatment capabilities, leading to greater investment in advanced medical linear particle accelerators. This growing patient population necessitates innovative and effective treatment options, thereby expanding the market for the same.

Various product developmental strategies such as clearances in the region by regulatory authorities in the region play a major role in pushing forward the revenue shares of medical linear particle accelerators in the region. For example, in October 2021, Panacea Medical Technologies, one of the world-leading manufacturers of advanced Radiation Oncology and Radiology equipment, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next-generation Stereotactic Body Radiotherapy (SBRT) enabled Linear Accelerator on a ring gantry platform.

Moreover, product launches by key market players in the region are further expected to propel the growth of the North America medical linear particle accelerator market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the medical linear particle accelerator market during the forecast period from 2024 to 2030.

Medical Linear Particle Accelerator Market key players:

Some of the key market players operating in the Medical Linear Particle Accelerator market include Elekta, Accuray Incorporated, SHINVA MEDICAL INSTRUMENT CO., LTD., VIEWRAY TECHNOLOGIES, INC., Altair Technologies, Inc., AccSys Technology, Inc., S.I.T. Sordina IORT Technologies S.p.A., Siemens Healthcare GmbH, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., MITSUBISHI HEAVY INDUSTRIES, LTD., and others.

Recent Developmental Activities in the Medical Linear Particle Accelerator Market:

  • In May 2023, GE HealthCare presented three new global innovations - Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite); that underscored the company's commitment to enhancing the radiation oncology care pathway.
  • In April 2021, Varian, a Siemens Healthineers company, signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further strengthened the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia.

Key takeaways from the Medical Linear Particle Accelerator market report study

  • Market size analysis for current medical linear particle accelerator market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the medical linear particle accelerator market
  • Various opportunities available for the other competitors in the medical linear particle accelerator market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current medical linear particle accelerator market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for medical linear particle accelerator market growth in the coming future?

Target audience who can be benefited from this Medical Linear Particle Accelerator market report study

  • Medical linear particle accelerator device providers
  • Research organizations and consulting companies
  • Medical linear particle accelerator related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in medical linear particle accelerator
  • Various end-users who want to know more about the medical linear particle accelerator market and the latest developments in the medical linear particle accelerator market

Frequently Asked Questions for the Medical Linear Particle Accelerator Market:

1. What are medical linear particle accelerators?

  • The medical linear particle accelerator are medical devices, which delivers high-energy x-rays or electrons. The x-rays or electrons are used to conform to a tumour's shape and destroy cancer cells while sparing surrounding normal tissue. The device is most commonly used for external beam radiation treatments for patients with cancer.

2. What is the market for medical linear particle accelerator?

  • The medical linear particle accelerator market was valued at USD 2.56 billion in 2023, growing at a CAGR of 4.79% during the forecast period from 2024 to 2030 to reach USD 3.39 billion by 2030.

3. What are the drivers for the medical linear particle accelerator market?

  • The medical linear particle accelerator market is experiencing significant growth due to the increasing cases of different types of cancers among the population, rising product developmental activities, and availability of a wide variety of medical linear particle accelerators that are acting as major factors contributing to the overall growth of the medical linear particle accelerator market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the medical linear particle accelerator market?

  • Some of the major market players operating in the medical linear particle accelerator market include Elekta, Accuray Incorporated, SHINVA MEDICAL INSTRUMENT CO., LTD., VIEWRAY TECHNOLOGIES, INC., Altair Technologies, Inc., AccSys Technology, Inc., S.I.T. Sordina IORT Technologies S.p.A., Siemens Healthcare GmbH, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., MITSUBISHI HEAVY INDUSTRIES, LTD., and others.

5. Which region has the highest share in the medical linear particle accelerator market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the medical linear particle accelerator market. This can be attributed to several factors such as rising cancer cases, and continuous advancement of technology in this field, which offers improved treatment features and efficiency, which are the major key factors that contribute to the growth of the medical linear particle accelerator market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Medical Linear Particle Accelerator Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Medical Linear Particle Accelerator Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Medical Linear Particle Accelerator Market Key Factors Analysis

  • 5.1. Medical Linear Particle Accelerator Market Drivers
    • 5.1.1. Increasing instances of cancers
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Availability of a wide variety of medical linear particle accelerator
  • 5.2. Medical Linear Particle Accelerator Market Restraints and Challenges
    • 5.2.1. Dearth of skilled specialists for equipment operation and handling
    • 5.2.2. Potential risks associated with medical linear particle accelerator
  • 5.3. Medical Linear Particle Accelerator Market Opportunities
    • 5.3.1. Integration with AI and Ml for precision
    • 5.3.2. Expansion into emerging market

6. Medical Linear Particle Accelerator Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Medical Linear Particle Accelerator Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Dedicated Linear Accelerator
    • 7.1.2. Non-Dedicated Linear Accelerator
  • 7.2. By Treatment Type
    • 7.2.1. Intensity Modulated Radiation Therapy
    • 7.2.2. Volumetric Modulated Arc Therapy
    • 7.2.3. Image Guided Radiation Therapy
    • 7.2.4. Stereotactic Radiosurgery/Stereotactic Body Radiotherapy
  • 7.3. By End-User
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Radiology Clinics
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Medical Linear Particle Accelerator market size in USD million (2021-2030)
      • 7.4.2.5. Spain Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.3.3. India Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Medical Linear Particle Accelerator Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Medical Linear Particle Accelerator Market Size in USD million (2021-2030)

8. Medical Linear Particle Accelerator Market Company and Product Profiles

  • 8.1. Elekta
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Accuray Incorporated
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. SHINVA MEDICAL INSTRUMENT CO., LTD.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. VIEWRAY TECHNOLOGIES, INC.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Altair Technologies, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. AccSys Technology, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. S.I.T. Sordina IORT Technologies S.p.A.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Siemens Healthcare GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Brainlab AG
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Panacea Medical Technologies Pvt. Ltd.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. MITSUBISHI HEAVY INDUSTRIES, LTD.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Medical Linear Particle Accelerator Market in Global (2021-2030)
  • Table 3: Medical Linear Particle Accelerator Market in Global by Product Type (2021-2030)
  • Table 4: Medical Linear Particle Accelerator Market in Global by Treatment Type (2021-2030)
  • Table 5: Medical Linear Particle Accelerator Market in Global by End-User (2021-2030)
  • Table 6: Medical Linear Particle Accelerator Market in Global by Geography (2021-2030)
  • Table 7: Medical Linear Particle Accelerator Market in North America (2021-2030)
  • Table 8: Medical Linear Particle Accelerator Market in the United States (2021-2030)
  • Table 9: Medical Linear Particle Accelerator Market in Canada (2021-2030)
  • Table 10: Medical Linear Particle Accelerator Market in Mexico (2021-2030)
  • Table 11: Medical Linear Particle Accelerator Market in Europe (2021-2030)
  • Table 12: Medical Linear Particle Accelerator Market in France (2021-2030)
  • Table 13: Medical Linear Particle Accelerator Market in Germany (2021-2030)
  • Table 14: Medical Linear Particle Accelerator Market in United Kingdom (2021-2030)
  • Table 15: Medical Linear Particle Accelerator Market in Italy (2021-2030)
  • Table 16: Medical Linear Particle Accelerator Market in Spain (2021-2030)
  • Table 17: Medical Linear Particle Accelerator Market in the Rest of Europe (2021-2030)
  • Table 18: Medical Linear Particle Accelerator Market in Asia-Pacific (2021-2030)
  • Table 19: Medical Linear Particle Accelerator Market in China (2021-2030)
  • Table 20: Medical Linear Particle Accelerator Market in Japan (2021-2030)
  • Table 21: Medical Linear Particle Accelerator Market in India (2021-2030)
  • Table 22: Medical Linear Particle Accelerator Market in Australia (2021-2030)
  • Table 23: Medical Linear Particle Accelerator Market in South Korea (2021-2030)
  • Table 24: Medical Linear Particle Accelerator Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Medical Linear Particle Accelerator Market in the Rest of the World (2021-2030)
  • Table 26: Medical Linear Particle Accelerator Market in the Middle East (2021-2030)
  • Table 27: Medical Linear Particle Accelerator Market in Africa (2021-2030)
  • Table 28: Medical Linear Particle Accelerator Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Medical Linear Particle Accelerator Market in Global (2021-2030)
  • Figure 3: Medical Linear Particle Accelerator Market in Global by Product Type (2021-2030)
  • Figure 4: Medical Linear Particle Accelerator Market in Global by Treatment Type (2021-2030)
  • Figure 5: Medical Linear Particle Accelerator Market in Global by End-User (2021-2030)
  • Figure 6: Medical Linear Particle Accelerator Market in Global by Geography (2021-2030)
  • Figure 7: Medical Linear Particle Accelerator Market in North America (2021-2030)
  • Figure 8: Medical Linear Particle Accelerator Market in the United States (2021-2030)
  • Figure 9: Medical Linear Particle Accelerator Market in Canada (2021-2030)
  • Figure 10: Medical Linear Particle Accelerator Market in Mexico (2021-2030)
  • Figure 11: Medical Linear Particle Accelerator Market in Europe (2021-2030)
  • Figure 12: Medical Linear Particle Accelerator Market in France (2021-2030)
  • Figure 13: Medical Linear Particle Accelerator Market in Germany (2021-2030)
  • Figure 14: Medical Linear Particle Accelerator Market in United Kingdom (2021-2030)
  • Figure 15: Medical Linear Particle Accelerator Market in Italy (2021-2030)
  • Figure 16: Medical Linear Particle Accelerator Market in Spain (2021-2030)
  • Figure 17: Medical Linear Particle Accelerator Market in the Rest of Europe (2021-2030)
  • Figure 18: Medical Linear Particle Accelerator Market in Asia-Pacific (2021-2030)
  • Figure 19: Medical Linear Particle Accelerator Market in China (2021-2030)
  • Figure 20: Medical Linear Particle Accelerator Market in Japan (2021-2030)
  • Figure 21: Medical Linear Particle Accelerator Market in India (2021-2030)
  • Figure 22: Medical Linear Particle Accelerator Market in Australia (2021-2030)
  • Figure 23: Medical Linear Particle Accelerator Market in South Korea (2021-2030)
  • Figure 24: Medical Linear Particle Accelerator Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Medical Linear Particle Accelerator Market in the Rest of the World (2021-2030)
  • Figure 26: Medical Linear Particle Accelerator Market in the Middle East (2021-2030)
  • Figure 27: Medical Linear Particle Accelerator Market in Africa (2021-2030)
  • Figure 28: Medical Linear Particle Accelerator Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis